91ÌÒÉ«

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91ÌÒÉ«

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91ÌÒÉ« Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91ÌÒÉ« Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Blood brain barrier: Cracking the hard nut

International Conference and Expo on Biopharmaceutics

Mohamed Ismail Nounou

Alexandria University, Egypt

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
The increase in incidence of brain disease, including cancer is alarming. In the Middle East, the incidence of primary brain cancer and secondary brain metastases originating mainly from breast, lung and/or ovarian cancer is on the rise because of increasing prevalence of these types of cancer. On the other hand, noninvasive drug therapy is hampered by poor access of most drugs to the brain due to the insurmountable blood�brain barrier (BBB). Nanotechnology holds great promise for a non-invasive therapy of severe brain diseases. Indeed, the literature reports provided evidence for enhanced drug transport across the BBB using nanocarriers, especially surface-modified polymeric nanoparticles (NPs).
Biography

Email: mohamed.nounou@alexu.edu.eg

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top